Coulter Partners secures Chief Executive Officer for ObsEva

Coulter Partners was delighted to partner with ObsEva SA (NASDAQ: OBSV / SIX: OBSN) to secure the appointment of Brian O’Callaghan as Chief Executive Officer and member of the company’s Executive Committee, effective 1 December 2020. He will succeed Dr Ernest Loumaye and be proposed for election on ObsEva’s Board of Directors at the next company AGM. ObsEva SA is a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health

Please refer to the press release published on November 9th 2020: ObsEva appoints Brian O'Callaghan as CEO

About Coulter Partners

Coulter Partners is a board and senior level executive search boutique focussed exclusively on global Life Sciences. From our offices in the UK, Europe, North America and Asia-Pacific, we work together across boundaries and disciplines to build outstanding leadership teams for our clients in the pharmaceuticals, biotechnology, medical devices, health tech, diagnostics, CRO and services sectors. Our industry leading reputation is founded on deep sector knowledge and innovative thinking. Our strategy is built on a unique team culture and true global reach. Our goal is to bring you the world’s best talent.